prostate biopsy for suspected prostate cancer

Comparision of Transrectal vs Transperineal biopsy in suspected carcinoma prostate - an open label non inferior randomised control trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087863

Enrollment

260

Registered

2025-05-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N428- Other specified disorders of prostate

Interventions

Intervention1: Transperineal Prostate Biopsy: Prostate biopsy will be taken through perineum route in one group of patients. Post transperineal biopsy results and complications will be assessed Cont

Eligibility

Inclusion criteria

Inclusion criteria: Adult males (40- 80 Years) who have indication of prostrate biopsy for detection of suspected prostrate CA with elevated PSA levels, abnormal DRE findings and/or abnormal TRUS/mpMRI findings

Exclusion criteria

Exclusion criteria: Previous history of CA prostrate, acute prostatitis or proven urinary tract infection

Design outcomes

Primary

Measure	Time frame
PRIMARY OBJECTIVE To compare the infectious complication rate between transperineal and transrectal biopsy Timepoint: 30 DAYS	—

Secondary

Measure	Time frame
SECONDARY OBJECTIVE To compare the non-infectious complication rates and detection rate between transperineal and transrectal biopsy for CA prostrate. Timepoint: 30 DAYS	—

Countries

India

Contacts

Public ContactRahul Bhatia

AIIMS Raipur

dramitsharma@aiimsraipur.edu.in8691898668

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026